This compound is a brominated quinolinone derivative used as a pharmaceutical intermediate. It features an amide group, an aromatic ring, an ether linkage, and a halogen substituent, with moderate lipophilicity and a polar surface area of 38.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 129722-34-5
1,4-Bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane
pharmaceutical impurity
7-(4-chlorobutoxy)-3,4-dihydro-2(1H)-quinolinone
pharmaceutical impurity reference standard
2-Chloro-4-(1H-pyrazol-3-yl)benzonitrile
pharmaceutical intermediate
(S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile
Pharmaceutical intermediate for darolutamide
3-acetyl-1H-pyrazole-5-carboxylic acid
pharmaceutical intermediate
Di-tert-butyl (2-oxopropane-1,3-diyl)dicarbamate
synthetic intermediate for midazolam impurities
7-Methoxy-3,4-dihydroquinolin-2(1H)-one
Pharmaceutical intermediate
3,4-Dihydro-7-hydroxy-2(1H)-quinolinone
pharmaceutical intermediate
7-(4-bromobutoxy)-3,4-dihydro-1H-quinolin-2-one
URHLNHVYMNBPEO-UHFFFAOYSA-N
C1CC(=O)NC2=C1C=CC(=C2)OCCCCBr